Shares of Gelteq Limited (NASDAQ:GELS – Get Free Report) rose 1.4% during mid-day trading on Tuesday . The company traded as high as $1.07 and last traded at $1.06. Approximately 10,157 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 182,839 shares. The stock had previously closed at $1.05.
Gelteq Stock Down 2.2 %
The business’s 50 day simple moving average is $1.86.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Gelteq stock. Citadel Advisors LLC bought a new stake in shares of Gelteq Limited (NASDAQ:GELS – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 23,748 shares of the company’s stock, valued at approximately $55,000. Citadel Advisors LLC owned about 0.25% of Gelteq at the end of the most recent reporting period.
Gelteq Company Profile
Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition.
Further Reading
- Five stocks we like better than Gelteq
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- What is a support level?
- Top 3 Beverage Stocks Pouring Out Profits
- What Are the U.K. Market Holidays? How to Invest and Trade
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Gelteq Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gelteq and related companies with MarketBeat.com's FREE daily email newsletter.
